Serum kallistatin level in comparison to other noninvasive panels for evaluating portal hypertension in Egyptian cirrhotic patients
Endoscopy · 01.06.2026 · 58 (S 03 S 03) · S421
DOI: 10.1055/s-0046-1821382 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.06.2026. Verfasst von A Farag und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Aims
To investigate the diagnostic value of serum kallistatin levels, along with other biochemical panels, in the assessment of portal hypertension among Egyptian individuals with liver cirrhosis ([ Table 1 ]).
Methods
This cross-sectional research evaluated 90 cirrhotic cases who were admitted to the National Liver Institute’s Hepatology and Gastroenterology Department as well as the Endoscopy Unit at Menoufia University by measuring the serum KAL level and comparing it to other panels in order to grade esophageal varices accordingto the results of GI endoscopy [ 1 ] [ 2 ] [ 3 ] [ 4 ] [ 5 ].
Results
The mean age of the 90 individuals who were enrolled in the study was 59.8±9.8 years; 42.2% of them were female, and 57.8% were male. Patients with varices had a considerably decreased mean level of blood kallistatin. Additionally, it demonstrates a notable decrease in individuals with extensive varices. The presence of EV can be predicted by kallistatin with a sensitivity of 76.5% and a specificity of 98.6% at cut-off levels of 23.1 μg/ml.
Conclusions
Serum kallistatin may serve as a potential indicator for identifying esophageal varices, particularlythe larger and more life-threatening types. Table 1 Variables No Varices OV grade I OV grade II OV grade III Test P-value King’s score Mean±SD 11.17±3.375 20.12±4.25 29.44±4.09 32.68±5.10 6.324 0.001* APRI Mean±SD 0.72±0.8 0.91±0.61 1.34±0.70 1.20±1.05 4.321 0.02* Evendo score Mean±SD 4.26±2.06 5.14±2.07 5.52±1.60 5.70±1.81 4.578 0.04* PC/SD Mean±SD 1140.96±674.09 855.36±662.70 825.0653±523.94 755.36±442.2 6.321 0.001* PLT(x10 3 /ml) Mean±SD 165.4±45.5 132.8±38 122.3±45.1 114.6±42.9 4.15 0.004* FIB-4 Mean±SD 3.13±2.98 4.26±2.13 5.15±2.85 6.93±3.35 5.995 0.003* KALLISTATIN (µg/ml) Mean±SD 25.4±5.24 16.1±4.24 13.12±3.99 12.83±4.3 5.158 0.001* Publication History Article published online: 05 June 2026 © 2026. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
Zitieren
APA
Farag, A., Abbasy, M., Nada, A., El-Abd, M., & Abdel-Samiee, M. (2026). Serum kallistatin level in comparison to other noninvasive panels for evaluating portal hypertension in Egyptian cirrhotic patients. Endoscopy, 58(S 03 S 03), S421. https://doi.org/10.1055/s-0046-1821382
Vancouver
Farag A, Abbasy M, Nada A, El-Abd M, Abdel-Samiee M. Serum kallistatin level in comparison to other noninvasive panels for evaluating portal hypertension in Egyptian cirrhotic patients. Endoscopy. 2026;58(S 03 S 03):S421. doi:10.1055/s-0046-1821382
BibTeX
@article{Farag2026,
author = {Farag, A and Abbasy, M and Nada, A and El-Abd, M and Abdel-Samiee, M},
title = {Serum kallistatin level in comparison to other noninvasive panels for evaluating portal hypertension in Egyptian cirrhotic patients},
journal = {Endoscopy},
year = {2026},
volume = {58},
number = {S 03 S 03},
pages = {S421},
doi = {10.1055/s-0046-1821382}
}
EUVIMED